The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Minimally invasive oesophagectomy.

This document replaces previous guidance on thoracoscopically assisted oesophagectomy (NICE interventional procedures guidance 189, August 2006).


Minimally invasive oesophagectomy can be used to remove part of the oesophagus (gullet), usually because of cancer. The procedure involves making small cuts or holes in the chest wall and inserting a camera and other instruments into the chest cavity in order to carry out the operation on the oesophagus.

Coding recommendations

The codes are dependent upon the extent of the excision; the procedure is classified using codes from one of the following two categories and fourth character detail will be required:

G02.- Total excision of oesophagus

Y74.4 Thoracoscopic video-assisted approach to thoracic cavity


G03.- Partial excision of oesophagus

Y74.4 Thoracoscopic video-assisted approach to thoracic cavity

Your responsibility

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account, and specifically any special arrangements relating to the introduction of new interventional procedures. The guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer. 

All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.

Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Providers should ensure that governance structures are in place to review, authorise and monitor the introduction of new devices and procedures.

Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

  • National Institute for Health and Care Excellence (NICE)